OpenAI Acquires Drug Development Startup Orchestra Bio
The AI lab is acquiring the startup to accelerate biopharma drug development using its technology.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
The odds
Each tick is a source publishing on this story
Price data
| Time | Chance of yes |
|---|---|
| now | 4% |
| 20 Oct, 21:34 UTC | 4% |
| 20 Oct, 13:13 UTC | 2% |
| 18 Oct, 18:50 UTC | 3% |
| 17 Oct, 16:23 UTC | 4% |
| 16 Oct, 22:55 UTC | 2% |
| 16 Oct, 14:38 UTC | 3% |
| 16 Oct, 02:23 UTC | 2% |
| 15 Oct, 16:56 UTC | 1% |
| 15 Oct, 13:10 UTC | 3% |
Replay the odds, article by article
Step through each article in the order it published and watch OpenAI respond.
The story so far
4 publishers have covered this in 4 articles since 20 Oct 2026. OpenAI published first, on 20 October at 00:00 UTC; theinformation.com followed 19h 55m later. The most recent article, from decrypt.co, appeared on 20 October at 21:46 UTC.
Outlets reporting it: TechCrunch (major outlet), OpenAI, theinformation.com, decrypt.co.
3 prediction markets price this story:
- OpenAI — the market puts it at 4%, with $21 traded in the last 24 hours, closing 1 Jan 2027. The outcome is Yes if OpenAI publicly confirms an initial public offering before January 1, 2027. The outcome is No if that confirmation does not happen by the deadline. Readers often mistake news about other companies like GlobalFoundries or TSMC as relevant to this specific market.
- OpenAI — the market puts it at 16%, with $94 traded in the last 24 hours, closing 1 Jan 2027. The outcome is Yes if OpenAI holds the top-ranked artificial intelligence model anywhere in the world before January 1, 2027. The outcome is No if it does not achieve this ranking by that date. Readers often mistake the deadline for the end of the year rather than the specific start of 2027.
- Will OpenAI have the best AI model at the end of October 2026? — the market puts it at 1%, with $6k traded in the last 24 hours, closing 31 Oct 2026. The market resolves by checking the arena.ai Text Arena leaderboard on October 31, 2026, at 12:00 PM ET. OpenAI wins if its model holds the highest rank among eligible models at that specific time and source. Readers often mistake the check date for the end of the month or overlook that auto-evaluated models are excluded from the ranking.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
How it unfolded
Every source in the order it published, with the odds on OpenAI at that moment. A dash means the source published before we started tracking prices.
- OpenAIOpenAI acquires Orchestra Bio3%
- theinformation.comOpenAI Buys Drug Development Company Orchestra Bio2%▼1 points since the previous source
- TechCrunchOpenAI acquires startup Orchestra Bio to beef up its biotech business2%
- decrypt.coOpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work4%▲2 points since the previous source
- Current odds4%
Sources
Every article we clustered into this story. Headlines link to the publisher.
Markets on this story
- Kalshi OpenAI 4% +1
Does the market have this right?
Wrong market?
- Kalshi OpenAI 16% −1
Does the market have this right?
Wrong market?
- Polymarket Will OpenAI have the best AI model at the end of October 2026? 1%
Does the market have this right?
Wrong market?
Have your say
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Email me when the odds move
In this story
- Orchestra Bio